524572 PHARMAID

Pharmaids Pharmaceuticals Share Price

₹69.00 +0.27 (0.39%)

04 Mar, 2025 06:34

SIP TrendupStart SIP in PHARMAID

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month -2.67%
  • Over 3 Month + 7.14%
  • Over 6 Month + 64.44%
  • Over 1 Year + 15%
SIP Lightning

Smart Investing Starts Here Start SIP with Pharmaids Pharmaceuticals for Steady Growth!

Invest Now

Pharmaids Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Pharmaids Pharmaceuticals Financials

Pharmaids Pharmaceuticals Technicals

EMA & SMA

Current Price
₹69.00
+ 0.27 (0.39%)
pointer
  • stock-down_img
  • Bearish Moving Average 3
  • stock-up_img
  • Bullish Moving Average 13
  • 20 Day
  • ₹68.33
  • 50 Day
  • ₹68.23
  • 100 Day
  • ₹64.44
  • 200 Day
  • ₹58.79

Resistance and Support

68.62 Pivot Speed
  • R3 73.52
  • R2 72.26
  • R1 69.88
  • S1 66.24
  • S2 64.98
  • S3 62.60

What's your outlook on Pharmaids Pharmaceuticals?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Pharmaids Pharms. has an operating revenue of Rs. 20.43 Cr. on a trailing 12-month basis. Pre-tax margin of -103% needs improvement, ROE of -11% is poor and needs improvement. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 24% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 19% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 16 which is a POOR score indicating inconsistency in earnings, a RS Rating of 86 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Pharmaids Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-12 Quarterly Results
2024-11-13 Quarterly Results
2024-05-28 Audited Results
2024-02-12 Quarterly Results
2024-01-06 Preferential issue of shares

Pharmaids Pharmaceuticals F&O

Pharmaids Pharmaceuticals Shareholding Pattern

5.22%
36.42%
58.36%

About Pharmaids Pharmaceuticals

  • NSE Symbol
  • PHARMAID
  • BSE Symbol
  • 524572
  • ISIN
  • INE117D01018

Similar Stocks to Pharmaids Pharmaceuticals

Pharmaids Pharmaceuticals FAQs

Pharmaids Pharmaceuticals share price is ₹69 As on 04 March, 2025 | 06:20

The Market Cap of Pharmaids Pharmaceuticals is ₹243.3 Cr As on 04 March, 2025 | 06:20

The P/E ratio of Pharmaids Pharmaceuticals is -19.7 As on 04 March, 2025 | 06:20

The PB ratio of Pharmaids Pharmaceuticals is 3.6 As on 04 March, 2025 | 06:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23